Anaut
Tokyo company whose EUREKA alpha software analyses real-time video from laparoscopic and robot-assisted surgery, using deep learning trained on large surgical-video datasets to highlight connective tissue and critical structures; it received MHLW/PMDA approval in 2024 as a software-as-a-medical-device.
Headquarters
Tokyo, Japan
Year Founded
2020
Founders
Nao Kobayashi (founder and CEO)
Country
Japan
Financial Information
Funding Stage
Series B (amount not disclosed)
Recent Funding
Not disclosed
Funding By
Japan Growth Capital Investment, JBIC, Beyond Next Ventures, ANRI, KSP
Core Technology
Deep learning on surgical video for real-time anatomical structure recognition
Product Type
Medical Device
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
None disclosed
Academic / Hospital Tie-ups
Not disclosed
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Japan's first approved SaMD augmenting surgeons' real-time visual recognition